Download PDF

Journal of Virological Methods

Publication date: 2013-10-01
Volume: 193 Pages: 135 - 139
Publisher: Elsevier/North-Holland Biomedical Press

Author:

Vinken, Lore
Megens, Sarah ; Schrooten, Yoeri ; Vandamme, Anne-Mieke ; Van Laethem, Kristel

Keywords:

Science & Technology, Life Sciences & Biomedicine, Biochemical Research Methods, Biotechnology & Applied Microbiology, Virology, Biochemistry & Molecular Biology, HIV-1, Genotyping, Editing, Drug resistance, Automation, DRUG-RESISTANCE, /r, AA, ART, EQA, FPR, NNRTI, NRTI, NT, PI, PR, RT, amino acid, antiretroviral therapy, env, envelope gene, external quality assessment, false positive rate, human immunodeficiency virus type 1, non-nucleoside reverse transcriptase inhibitor, nucleoside reverse transcriptase inhibitor, nucleotide, pol, polymerase gene, protease, protease inhibitor, reverse transcriptase, ritonavir boosted, Automation, Laboratory, Computational Biology, Humans, Microbial Sensitivity Tests, Sequence Analysis, DNA, 0605 Microbiology, 1108 Medical Microbiology, 3207 Medical microbiology

Abstract:

Genotypic drug resistance testing is routine practice in HIV-1 clinical care. The visual interpretation of sequencing electropherograms is labour-intensive and subject to intra- and inter-assay variability because decisions are based on operators' judgments. In this study the performance of the automatic editing tool RECall was compared to the current standard of editing manually and editing using the tool ViroSeq. Using RECall a consensus sequence could be generated for 97% of the V3 loop and for 79% of the pol experiments. By comparison, using manual editing a consensus sequence could be reached for 87% of the V3 and 87% of the pol experiments. Using ViroSeq, a consensus sequence was generated for 68% of the pol experiments. On a predefined dataset, manual editing displayed the highest probability to accurately assign mixtures (0.91 vs. 0.88 by ViroSeq vs. 0.76 by RECall) and the lowest probability to inaccurately assign a mixture to a pure base call (0.002 vs. 0.019 by ViroSeq vs. 0.002 by RECall). As differences in base calling have little impact on drug resistance interpretation and hands-on-time could be substantially reduced, RECall could be a valuable tool for the standardization and acceleration of the editing process.